WallStSmart
MBRX

Moleculin Biotech Inc

NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY

$2.48
-0.40% today

Updated 2026-05-06

Market cap
$13.39M
P/E ratio
P/S ratio
EPS (TTM)
$-28.42
Dividend yield
52W range
$2 – $29
Volume
0.1M

Moleculin Biotech Inc (MBRX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+44.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+966.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-6.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-11.0%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-19$4.83+179.0%$2.08$2.06-1.0%
2025-11-13$-0.68+45.6%$0.49$0.43-11.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-6.11$4.83+179.0%
2025-09-30$-1.25$-0.68+45.6%
2025-06-30$-0.40$-0.49-22.5%
2025-03-31$-0.56$-0.69-23.2%$63000.00-84.5%
2024-12-31$-1.28$-0.56+56.6%$126000.00-69.0%
2024-09-30$-2.44$-2.85-16.8%
2024-06-30$-2.51$-1.70+32.3%
2024-03-31$-3.53$-2.02+42.8%$406000.00
2023-12-31$-3.05$-5.02-64.6%$406000.00
2023-09-30$-0.24$-0.19+20.8%
2023-06-30$-0.27$-0.20+25.9%
2023-03-31$-0.25$-0.28-12.0%

Frequently asked questions

Has Moleculin Biotech Inc beaten earnings estimates?
Moleculin Biotech Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +44.7% over the last 4 quarters.
How does MBRX stock react to earnings?
MBRX stock has moved an average of -6.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.